Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BZ371A Gel for Post-Prostatectomy Erectile Dysfunction
NCT05558007Phase 2Recruiting
- Sponsor
- Biozeus
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bz371a in erectile dysfunction (ED), sponsored by Biozeus. Started Nov 2023; status: recruiting.
02
Drugs
bz371a
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05558007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05558007.